Aspirin Concept

subject area of

• 'MacDope': a simulation of drug disposition in the human body: applications in clinical pharmacokinetics.  Academic Article
• 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Academic Article
• A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement  Academic Article
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease  Academic Article
• A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction  Academic Article
• A Pulsed Tangential-Flow Ultrafiltration Technique for Studying Protein-Drug Binding  Academic Article
• A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo  Academic Article
• A fulminant neurologic presentation of systemic lupus erythematosus  Academic Article
• A guide to GRADE guidelines for the readers of JTH  Academic Article
• A novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a multicenter randomized control crossover trial  Academic Article
• A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes  Academic Article
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)  Academic Article
• A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract  Academic Article
• A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin  Academic Article
• A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip  Academic Article
• A study of the bioavailability and platelet inhibitory effects of a new enteric-coated acetylsalicylic acid preparation  Academic Article
• A survey evaluating surgeons’ peri-operative usage of acetyl-salicylic acid (ASA) and their willingness to enroll their patients in a perioperative ASA randomized controlled trial  Academic Article
• ANTIPLATELET AGENTS: THEIR ROLE IN THE PREVENTION OF SUDDEN DEATH  Academic Article
• ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?  Academic Article
• ASPIRIN AND FIBRINOLYSIS  Academic Article
• Abnormal prostaglandin E2 production blocks myogenic differentiation in myotonic dystrophy  Academic Article
• Acetylsalicylic acid (ASA) increases the solubility of cholesterol when incorporated in lipid membranes  Academic Article
• Acid-NSAID/Aspirin Interaction in Peptic Ulcer Disease  Academic Article
• Active metabolite concentration of clopidogrel in patients taking different doses of aspirin: results of the interaction trial  Academic Article
• Acute in vitro effects of ethanol on responses of platelets from cholesterol-fed and Watanabe heritable hyperlipidemic rabbits.  Academic Article
• Acute stroke management.  Academic Article
• Adding aspirin to clopidogrel after TIA and ischemic stroke: Benefits do not match risks  Academic Article
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation  Academic Article
• Adjunctive therapy for myocardial infarction.  Academic Article
• Advances in Antithrombotic Therapy  Academic Article
• Advances in Antithrombotic Therapy: Novel Agents  Academic Article
• Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry  Academic Article
• Angina (unstable).  Academic Article
• Angina (unstable).  Academic Article
• Angina (unstable).  Academic Article
• Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia  Academic Article
• Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?  Academic Article
• Anticoagulants in acute coronary syndromes  Academic Article
• Anticoagulation therapy in the antiphospholipid syndrome: recent advances  Academic Article
• Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.  Academic Article
• Antiphospholipid antibody syndrome  Academic Article
• Antiplatelet Agents: Rationale and Results  Academic Article
• Antiplatelet Drugs  Academic Article
• Antiplatelet Drugs  Academic Article
• Antiplatelet Therapy  Academic Article
• Antiplatelet Therapy and Vascular-Access Patency  Academic Article
• Antiplatelet Therapy in Cerebral Small Vessel Disease  Academic Article
• Antiplatelet drugs  Academic Article
• Antiplatelet drugs in thromboembolism  Academic Article
• Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Academic Article
• Antiplatelet therapy in the management of atherothrombosis: recent clinical advances  Academic Article
• Antithrombotic Agents  Academic Article
• Antithrombotic Agents in Coronary Artery Disease  Academic Article
• Antithrombotic Agents in Coronary Artery Disease  Academic Article
• Antithrombotic Drugs  Academic Article
• Antithrombotic Therapy During Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy for Atrial Fibrillation  Academic Article
• Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes  Academic Article
• Antithrombotic Therapy in Neonates and Children  Academic Article
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Academic Article
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Academic Article
• Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts  Academic Article
• Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making  Academic Article
• Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.  Academic Article
• Antithrombotic therapy in atrial fibrillation.  Academic Article
• Antithrombotic therapy. Introduction.  Academic Article
• Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source  Academic Article
• Apixaban in Patients with Atrial Fibrillation  Academic Article
• Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial  Academic Article
• Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome  Academic Article
• Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease  Academic Article
• Appropriate Assessment of the Functional Consequences of Platelet Cyclooxygenase-1 Inhibition by Aspirin in vivo  Academic Article
• Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.  Academic Article
• Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials  Academic Article
• Aspirin  Academic Article
• Aspirin Use and Risk of Subdural Hematoma: Updated Meta-Analysis of Randomized Trials  Academic Article
• Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty  Academic Article
• Aspirin Versus Low-Molecular-Weight Heparin for Ischemic Stroke in Children: An Unanswered Question  Academic Article
• Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke  Academic Article
• Aspirin and clonidine in non-cardiac surgery: acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial  Academic Article
• Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.  Academic Article
• Aspirin and fibrinolysis in acute myocardial infarction: Meta-analytic evidence for synergy  Academic Article
• Aspirin and heparin to improve live birth rate in IVF for unexplained implantation failure?  Academic Article
• Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects  Academic Article
• Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects.  Academic Article
• Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects.  Academic Article
• Aspirin for Acute Coronary Syndromes: Have We Learned the Correct Dose Yet?  Academic Article
• Aspirin for Dual Prevention of Venous and Arterial Thrombosis  Academic Article
• Aspirin for Preventing Venous Thromboembolism  Academic Article
• Aspirin for Prevention and Treatment of Cardiovascular Disease  Academic Article
• Aspirin for preventing venous thromboembolism.  Academic Article
• Aspirin for preventing venous thromboembolism.  Academic Article
• Aspirin for primary prevention of stroke in individuals without cardiovascular disease—A meta-analysis  Academic Article
• Aspirin for the Prevention of Recurrent Venous Thromboembolism  Academic Article
• Aspirin for the primary prevention of cardiovascular events  Academic Article
• Aspirin improves the outcome of intra-arterial thrombolysis with tissue plasminogen activator  Academic Article
• Aspirin in Patients Undergoing Noncardiac Surgery  Academic Article
• Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery  Academic Article
• Aspirin in prevention of cardiovascular events. Dr. Gordon Guyatt in an interview with Dr. Roman Jaeschke  Academic Article
• Aspirin in secondary prevention of recurrent venous thromboembolism  Academic Article
• Aspirin in the prevention of cancer  Academic Article
• Aspirin in the treatment of cardiovascular disease: A review  Academic Article
• Aspirin inhibits formation of cholesterol rafts in fluid lipid membranes  Academic Article
• Aspirin inhibits platelet function independent of the acetylation of ciclo-oxygenase  Academic Article
• Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty  Academic Article
• Aspirin plus clopidogrel was not linked to risk for cancer compared with aspirin alone or no antiplatelets  Academic Article
• Aspirin resistance  Academic Article
• Aspirin resistance  Academic Article
• Aspirin resistance and its implications in clinical practice.  Academic Article
• Aspirin resistance: Table 1  Academic Article
• Aspirin resistance: does it exist and is it an important clinical problem?  Academic Article
• Aspirin resistance: position paper of the Working Group on Aspirin Resistance  Academic Article
• Aspirin resistance:a new independent predictor of vascular events?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do no necessarily represent the views of JACCor the American College of Cardiology.  Academic Article
• Aspirin response variability after major orthopedic surgery  Academic Article
• Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding  Academic Article
• Aspirin tolerance and leukotriene biosynthesis in Churg-Strauss syndrome  Academic Article
• Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial  Academic Article
• Aspirin, Sulfinpyrazone, or Both in Unstable Angina  Academic Article
• Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events  Academic Article
• Aspirin: its effect on platelet glycolysis and release of adenosine diphosphate.  Academic Article
• Assessment of antithrombotic drugs ex vivo and in vivo.  Academic Article
• Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes  Academic Article
• Association of cyclooxygenase-2 genetic variant with cardiovascular disease  Academic Article
• Association of renin–angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study  Academic Article
• Atrial Fibrillation and PCI — Do We Still Need Aspirin?  Academic Article
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.  Academic Article
• Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups  Academic Article
• Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range  Academic Article
• Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome  Academic Article
• Benefits and harms of aspirin desensitization for aspirin‐exacerbated respiratory disease: a systematic review and meta‐analysis  Academic Article
• Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin  Academic Article
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin  Academic Article
• Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis  Academic Article
• Bleeding associated with antithrombotic therapy.  Academic Article
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter  Academic Article
• Canadian Spontaneous Coronary Artery Dissection Cohort Study  Academic Article
• Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events  Academic Article
• Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks  Academic Article
• Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib  Academic Article
• Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease  Academic Article
• Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention  Academic Article
• Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-90.  Academic Article
• Changes over time in the use of aspirin in patients hospitalized with acute myocardial infarction (1975 to 1997): A population-based perspective  Academic Article
• Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source  Academic Article
• Characteristics of sudden potential drop in bullfrog gastric mucosa  Academic Article
• Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial  Academic Article
• Chemistry, Measurement, and Clinical Significance of Platelet Specific Proteins  Academic Article
• Clinical decisions. Management of stable coronary disease.  Academic Article
• Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials  Academic Article
• Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin  Academic Article
• Clinical potential of antithrombotic drugs in coronary syndromes  Academic Article
• Clinical therapeutic trial of aspirin and azapropazone in rheumatoid arthritis when prescribed singly and in combination  Academic Article
• Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)  Academic Article
• Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events  Academic Article
• Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes  Academic Article
• Clopidogrel plus aspirin in atrial fibrillation.  Academic Article
• Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis  Academic Article
• Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial  Academic Article
• Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial  Academic Article
• Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial  Academic Article
• Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease  Academic Article
• Combination Therapy to Prevent Cardiovascular Disease  Academic Article
• Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?  Academic Article
• Combined Antiplatelet Therapy in Atrial Fibrillation:  Academic Article
• Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease  Academic Article
• Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?  Academic Article
• Comorbidities associated with eosinophilic chronic rhinosinusitis: A systematic review and meta‐analysis  Academic Article
• Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations  Academic Article
• Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis  Academic Article
• Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett’s neoplasia in the AspECT Barrett’s chemoprevention trial pathology audit  Academic Article
• Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades  Academic Article
• Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis  Academic Article
• Comparison of High-Dose With Low-Dose Aspirin in Patients With Mechanical Heart Valve Replacement Treated With Oral Anticoagulant  Academic Article
• Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events  Academic Article
• Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease  Academic Article
• Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura  Academic Article
• Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular Diseases  Academic Article
• Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II  Academic Article
• Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?  Academic Article
• Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: Direct measurement of percent release of β-thromboglobulin and assessment by flow cytometry of P-selectin expression \textbar Request PDF  Article
• Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin  Academic Article
• Controlled trial of clinical utility of serum salicylate monitoring in rheumatoid arthritis.  Academic Article
• Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease—How to Choose  Academic Article
• Coronary artery stenting in patients treated by clopidogrel without aspirin  Academic Article
• Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND)  Academic Article
• Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: A long-term analysis based on the CURE trial  Academic Article
• Critical evaluation of platelet-inhibiting drugs in thrombotic disease.  Academic Article
• Current Status of Chemoprevention in Barrett’s Esophagus  Academic Article
• Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin  Academic Article
• Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint  Academic Article
• Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective  Academic Article
• Delivery of passivating proteins to sutures during passage through the vessel wall reduces subsequent platelet deposition by blocking fibrinogen adsorption.  Academic Article
• Dermatomyositis associated with platelet thrombi formation and responsive to antiplatelet therapy.  Academic Article
• Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy  Academic Article
• Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis  Academic Article
• Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) trial  Academic Article
• Dielectric Relaxation and Crystallization of Ultraviscous Melt and Glassy States of Aspirin, Ibuprofen, Progesterone, and Quinidine  Academic Article
• Dielectric Study of Equimolar Acetaminophen–Aspirin, Acetaminophen–Quinidine, and Benzoic Acid–Progesterone Molecular Alloys in the Glass and Ultraviscous States and Their Relevance to Solubility and Stability  Academic Article
• Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practice  Academic Article
• Differences in inhibition of PGI2 production by aspirin in rabbit artery and vein segments  Academic Article
• Different perspective on ASA use.  Academic Article
• Dipyridamole disposition after chronic administration: Effect of aspirin  Academic Article
• Divergent effects of aspirin and salicylate on glucose and glycogen metabolism in human platelets  Academic Article
• Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?  Academic Article
• Does aspirin really reduce the risk of colon cancer?  Academic Article
• Does long term aspirin prevent cancer?  Academic Article
• Does the long-term use of aspirin decrease the risk of death due to cancer?  Academic Article
• Dose Antiplatelet Agents; The Relationship Among Side Effects, and Antithrombotic Effectiveness  Academic Article
• Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes  Academic Article
• Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial  Academic Article
• Drug Effects on Platelet Adherence to Collagen and Damaged Vessel Walls \textbar Request PDF  Article
• Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions  Academic Article
• Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence  Academic Article
• Dual and triple antithrombotic therapies: current patterns of practice and controversies  Academic Article
• Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society  Academic Article
• Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline  Academic Article
• Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events  Academic Article
• Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score  Academic Article
• Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances.  Academic Article
• ESPRIT trial  Academic Article
• Early Recovery and Functional Outcome are Related with Causal Stroke Subtype: Data from the Tinzaparin in Acute Ischemic Stroke Trial  Academic Article
• Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes  Academic Article
• Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome  Academic Article
• Effect of Addition of Clopidogrel to Aspirin on Stroke Incidence: Meta-Analysis of Randomized Trials  Academic Article
• Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect  Academic Article
• Effect of Aspirin and ibuprofen either alone or in combination on gastric mucosa and bleeding time and on serum prostaglandin E2 and thromboxane A2 levels in the anaesthetized rats in vivo  Academic Article
• Effect of Aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation  Academic Article
• Effect of Aspirin on Hemostasis and Thrombosis  Academic Article
• Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease  Academic Article
• Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation  Academic Article
• Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke  Academic Article
• Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model  Academic Article
• Effect of Drugs on Platelets and Complications of Vascular Disease  Article
• Effect of PCI on Quality of Life in Patients with Stable Coronary Disease  Academic Article
• Effect of Pressure on Molecular and Ionic Motions in Ultraviscous Acetaminophen–Aspirin Mixture  Academic Article
• Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial  Academic Article
• Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study  Academic Article
• Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits.  Academic Article
• Effect of aspirin in vascular surgery in patients from a randomized clinical trial (POISE-2)  Academic Article
• Effect of calcium concentration and inhibitors on the responses of platelets stimulated with collagen: Contrast between human and rabbit platelets  Academic Article
• Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists  Academic Article
• Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease  Academic Article
• Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent collagen \textbar Request PDF  Article
• Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease – a randomized crossover trial  Academic Article
• Effect of prostaglandin synthesis inhibitors on spontaneous and endotoxin-induced abortion in mice  Academic Article
• Effective, selective and specific inhibition of COX-1 may overcome the “aspirin paradox”  Academic Article
• Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials  Academic Article
• Effectiveness of Anticoagulants  Academic Article
• Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patienis undergoing elective knee surgery  Academic Article
• Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study  Academic Article
• Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes  Academic Article
• Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation  Academic Article
• Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial  Academic Article
• Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study  Academic Article
• Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease  Academic Article
• Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study  Academic Article
• Effects of aspirin, naloxone and placebo  Academic Article
• Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma  Academic Article
• Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma.  Academic Article
• Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial  Academic Article
• Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review  Academic Article
• Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina  Academic Article
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study  Academic Article
• Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis  Academic Article
• Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme  Academic Article
• Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial  Academic Article
• Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial  Academic Article
• Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials  Academic Article
• Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease  Academic Article
• Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD  Academic Article
• Efficacy of Antiplatelet Therapy in Secondary Prevention Following Lacunar Stroke  Academic Article
• Eicosapentaenoic Acid Interferes with U46619-Stimulated Formation of Inositol Phosphates in Washed Rabbit Platelets  Academic Article
• Endothelial Cells Produce a Lipoxygenase Derived Chemo-Repellent which Influences Platelet/Endothelial Cell Interactions – Effect of Aspirin and Salicylate  Academic Article
• Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial  Academic Article
• Enzyme Activities on the Platelet Surface in Relation to the Action of Adenosine Diphosphate  Article
• Eosinophilic Asthma  Academic Article
• Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial  Academic Article
• Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial  Academic Article
• Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials  Academic Article
• Evidence based treatment of the antiphospholipid syndromeII. Optimal anticoagulant therapy for thrombosis  Academic Article
• Evidence-based treatment of the antiphospholipid syndrome  Academic Article
• External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry  Academic Article
• External applicability of the COMPASS trial: the Western Denmark Heart Registry  Academic Article
• Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards  Academic Article
• Factors responsible for ADP-induced release reaction of human platelets  Article
• Failure of Aspirin plus Dipyridamole To Prevent Restenosis after Carotid Endarterectomy  Academic Article
• Failure of Aspirin to Prevent Atherothrombosis  Academic Article
• Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis  Academic Article
• Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy  Academic Article
• Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial  Academic Article
• From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE)  Academic Article
• Functional Abilities of an International Post-Stroke Population: Standard Assessment of Global Everyday Activities (SAGEA) Scale  Academic Article
• Further thoughts on the importance of models in the assessment of clinical evidence  Academic Article
• Hacked by the Russians  Academic Article
• Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Heart failure.  Academic Article
• Hemorrhagic Complications of Anticoagulant Therapy  Academic Article
• Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss  Academic Article
• Heparin-induced thrombocytopenia in renal failure.  Academic Article
• High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source  Academic Article
• Hirulog in the Treatment of Unstable Angina  Academic Article
• How Should Results from Completed Studies Influence Ongoing Clinical Trials?  Academic Article
• How can the results of the COMPASS trial benefit patients with coronary or peripheral artery disease in Poland?  Academic Article
• How can we reduce disagreement among guidelines for venous thromboembolism prevention?  Academic Article
• How good is aspirin for patients with acute brain ischaemia?  Academic Article
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction  Academic Article
• Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin  Academic Article
• Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease  Academic Article
• Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel  Academic Article
• Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE])  Academic Article
• Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry  Academic Article
• Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial  Academic Article
• Impacts of metformin and aspirin on life history features and longevity of crickets: trade-offs versus cost-free life extension?  Academic Article
• In Barrett esophagus, high- vs low-dose esomeprazole improved clinical outcomes; aspirin vs no aspirin did not  Academic Article
• In healthy older adults, daily aspirin increased cancer mortality  Academic Article
• In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding  Academic Article
• Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy  Academic Article
• Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid  Academic Article
• Increased Platelet Destruction  Academic Article
• Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel  Academic Article
• Increased dipyridamole plasma concentrations associated with salicylate administration. Relationship to effects on platelet aggregation in vivo  Academic Article
• Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation  Academic Article
• Independent predictors of stroke in patients with atrial fibrillation: A systematic review  Academic Article
• Indirect comparison: relative risk fallacies and odds solution  Academic Article
• Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale  Academic Article
• Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention  Academic Article
• Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women  Academic Article
• Influence of a critical path management tool in the treatment of acute myocardial infarction. Clinical Quality Improvement Network Investigators.  Academic Article
• Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes  Academic Article
• Inhibition of COX pathway in experimental myocardial infarction.  Academic Article
• Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction  Academic Article
• Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia  Academic Article
• Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study  Academic Article
• Injury Of Cultured Endothelial Cells By Thrombin-Stimulated Platelets  Article
• Inositol phospholipid metabolism in human platelets stimulated by ADP  Academic Article
• Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial  Academic Article
• Intensity and Quality of Warfarin Anticoagulation in Chinese Patients  Academic Article
• Interaction of Aspirin (Acetylsalicylic Acid) with Lipid Membranes  Academic Article
• International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding  Academic Article
• Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy  Academic Article
• Investigation and management of erythrocytosis  Academic Article
• Is Daily Low-Dose Aspirin Safe to Take Following Laparoscopic Roux-en-Y Gastric Bypass for Obesity Surgery?  Academic Article
• Is aspirin safer than a direct oral anticoagulant for patients with atrial fibrillation at high risk of bleeding?  Academic Article
• Is there a benefit of low-dose aspirin in assisted reproduction?  Academic Article
• Is there a role for laboratory testing to identify patients at risk of aspirin treatment failure?  Academic Article
• Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion.  Academic Article
• Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016–2017  Academic Article
• Left Atrial Enlargement Could Be Detected on Extended Computed Tomography Angiography Within Initial Stroke Assessment—Reply  Academic Article
• Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin  Academic Article
• Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke  Academic Article
• Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction  Academic Article
• Lipoxins and Aspirin-Triggered Lipoxins in Airway Responses  Academic Article
• Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension Trials  Academic Article
• Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction  Academic Article
• Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial  Academic Article
• Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event  Academic Article
• Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis  Academic Article
• Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.  Academic Article
• Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment  Academic Article
• Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism  Academic Article
• Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture  Academic Article
• Low-dose Aspirin and Cancer Mortality: A Meta-analysis of Randomized Trials  Academic Article
• Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial  Academic Article
• Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials  Academic Article
• Low-dose rivaroxaban plus aspirin for the prevention of cardiovascular events: an evaluation of COMPASS  Academic Article
• Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial  Academic Article
• Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial  Academic Article
• Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.  Academic Article
• Lowering of plasma isoxicam concentrations with acetylsalicylic acid.  Academic Article
• Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease  Academic Article
• Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin  Academic Article
• Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy  Academic Article
• Management of acute coronary syndromes in developing countries: acute coronary events-a multinational survey of current management strategies.  Academic Article
• Mechanism of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187 \textbar Request PDF  Article
• Mechanisms of Aspirin-Intolerant Asthma: Identifying Inflammatory Pathways in the Pathogenesis of Asthma  Academic Article
• Meta-analyses of the effects of thrombolysis and aspirin on clinical outcomes  Academic Article
• Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity  Academic Article
• Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source  Academic Article
• Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions  Academic Article
• Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS ₂ and CHA ₂ DS ₂ -VASc Scores in Patients With Atrial Fibrillation  Academic Article
• Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation  Academic Article
• Modification of platelet function  Article
• Monitoring Emerging Data From the COMPASS Trial of an Antithrombotic Agent  Academic Article
• Monitoring the ACTIVE-W trial: Some issues in monitoring a noninferiority trial  Academic Article
• Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease  Academic Article
• Mortality Risk and Patterns of Practice in 2,070 Patients With Acute Myocardial Infarction, 1987-92  Academic Article
• Mortality benefit in the COMPASS trial: is it related to superior statistical power or better efficacy and safety?  Academic Article
• Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W  Academic Article
• Multiple daily doses of acetyl‐salicylic acid (ASA) overcome reduced platelet response to once‐daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial  Academic Article
• Myocardial Infarction, Peptic Ulcer and Acetylsalicylic Acid: Of Good and Evil  Academic Article
• Myocardial injury after non-cardiac surgery: diagnosis and management  Academic Article
• Myocardial injury after noncardiac surgery  Academic Article
• Myths and facts in the use of anti-inflammatory drugs  Academic Article
• Nasal polyps, bronchial asthma and aspirin sensitivity.  Academic Article
• Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable  Academic Article
• New Antithrombotic Drugs: Beyond Aspirin and Heparin  Academic Article
• New antithrombotic agents—insights from clinical trials  Academic Article
• Non-Steroidal Anti-Inflammatory Agents and Coronary Heart Disease  Academic Article
• Non-variceal upper gastrointestinal bleeding  Academic Article
• Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study  Academic Article
• On the nonlinear variation of dc conductivity with dielectric relaxation time  Academic Article
• Once versus twice daily aspirin after coronary bypass surgery: a randomized trial  Academic Article
• One-year Results of a Factorial Randomized Trial of Aspirin versus Placebo and Clonidine versus Placebo in Patients Having Noncardiac Surgery  Academic Article
• Optimal dose for starting and maintaining low-dose aspirin  Academic Article
• Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis  Academic Article
• Oral Anticoagulant Therapy in Patients with Coronary Artery Disease  Academic Article
• Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease  Academic Article
• Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation  Academic Article
• Oral Anticoagulants vs. Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Verdict is in  Academic Article
• Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease  Academic Article
• Oral anticoagulants in patients with coronary artery disease  Academic Article
• Oral anticoagulants in patients with coronary artery disease: an inexpensive and effective strategy  Academic Article
• Oral antiplatelet therapy.  Academic Article
• Oral factor Xa inhibitors and risk of subdural hematoma  Academic Article
• Outcomes of Acute Coronary Syndrome in a Large Canadian Cohort: Impact of Chronic Renal Insufficiency, Cardiac Interventions, and Anemia  Conference Paper
• Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.  Academic Article
• Overexpression of the Multidrug Resistance Protein-4 Transporter in Patients Undergoing Coronary Artery Bypass Graft Surgery  Academic Article
• Overview of Therapeutic Approaches for Cholesterol Lowering and Attenuation of Thrombosis for Prevention of Atherothrombosis  Academic Article
• Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification  Academic Article
• PLATELET SUPPRESSIVE THERAPY  Academic Article
• PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients  Academic Article
• Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro  Academic Article
• Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways  Academic Article
• Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease  Academic Article
• Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial  Academic Article
• Part 9: Acute Coronary Syndromes  Academic Article
• Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes  Article
• Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry  Academic Article
• Patients with Peripheral Artery Disease in the COMPASS Trial  Academic Article
• Peptic ulcer disease today  Academic Article
• Periodic health examination, 1991 update: 6. Acetylsalicylic acid and the primary prevention of cardiovascular disease. Canadian Task Force on the Periodic Health Examination.  Academic Article
• Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury  Academic Article
• Perioperative Aspirin for Prevention of Venous Thromboembolism  Academic Article
• Perioperative Management of Antiplatelet Therapy in Patients With a Coronary Stent Who Need Noncardiac Surgery  Academic Article
• Perioperative Management of Antithrombotic Therapy  Academic Article
• Perioperative Management of Patients Receiving Anticoagulant or Antiplatelet Therapy: A Clinician-Oriented and Practical Approach  Academic Article
• Perioperative Treatment With Aspirin or Clonidine and Risk of Acute Kidney Injury—Reply  Academic Article
• Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis  Academic Article
• Physicians' recommendations for patients who undergo noncardiac surgery.  Academic Article
• Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future  Academic Article
• Platelet Interactions with the Endothelium and the Subendothelium: the Role of Thrombin and Prostacyclin  Academic Article
• Platelet activating factor: Regulation by mast cells and aspirin  Academic Article
• Platelet inhibitors in the treatment of thrombosis.  Academic Article
• Platelet tests and antiplatelet drugs in coronary artery disease.  Academic Article
• Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects  Academic Article
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Academic Article
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Academic Article
• Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease  Academic Article
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.  Academic Article
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects.  Academic Article
• Platelets and Thrombosis in the Development of Atherosclerosis and Its Complications  Article
• Platelets.  Academic Article
• Point-of-care testing for assessment of adequacy of oral antiplatelet therapy in patients with cardiovascular disease  Academic Article
• Polypill for Cardiovascular Disease Prevention—Reply  Academic Article
• Polypill with or without Aspirin in Persons without Cardiovascular Disease  Academic Article
• Polypill: the evidence and the promise  Academic Article
• Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: Results from a randomized controlled trial of aspirin versus low molecular weight heparin  Academic Article
• Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial  Academic Article
• Pre-Hospital Cardiac Arrest in Acute Coronary Syndromes: Insights from the Global Registry of Acute Coronary Events and the Canadian Registry of Acute Coronary Events  Academic Article
• Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism  Academic Article
• Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A])  Academic Article
• Predictors of Mortality in Patients With Lacunar Stroke in the Secondary Prevention of Small Subcortical Strokes Trial  Academic Article
• Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial  Academic Article
• Preeclampsia  Academic Article
• Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making  Academic Article
• Preservation of platelets during extracorporeal circulation in sheep. A comparison between aspirin and sulfinpyrazone.  Academic Article
• Preventing stroke in patients with atrial fibrillation: Current treatments and new concepts  Academic Article
• Prevention of Thromboembolic Events After Bioprosthetic Aortic Valve Replacement  Academic Article
• Prevention of Vascular Events in Patients with Atrial Fibrillation:  Academic Article
• Prevention of Venous Thromboembolism  Academic Article
• Prevention of Venous Thromboembolism After Hip or Knee Arthroplasty  Academic Article
• Prevention of activation of blood coagulation during acute coronary ischemic syndromes beyond aspirin and heparin  Academic Article
• Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone  Academic Article
• Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness  Academic Article
• Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)  Academic Article
• Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial  Academic Article
• Prevention of thrombosis in antiphospholipid syndrome  Academic Article
• Primary thrombocythaemia in childhood: Symptomatic episodes and their relationship thromboxane A2, 6-keto-PGE1 and 12-hydroxy-eicosatetraenoic acid production: A case report  Academic Article
• Principles and practice of coronary thrombolysis and conjunctive treatment  Academic Article
• Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”  Academic Article
• Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.  Academic Article
• Proceedings: Failure of aspirin and dipyridamole to influence the incidence of leg scan detected venous thrombosis after elective hip surgery.  Academic Article
• Proceedings: Inhibition of collagen- or thrombin-induced shape change of rabbit platelets  Academic Article
• Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness.  Academic Article
• Prophylaxis of venous thromboembolism. An overview.  Academic Article
• Prostacyclin and thromboxane generating systems in rabbits pretreated with aspirin  Academic Article
• Prostaglandin I2 (prostacyclin).  Academic Article
• Prostaglandins and Platelets  Academic Article
• Proton Pump Inhibitors and Clopidogrel – Hazardous Drug Interaction or Hazardous Interpretation of Data?  Academic Article
• Prévention des complications vasculaires après ischémie cérébrale d'origine artérielle. Étude ESPRIT: anticoagulation modérée, association aspirine-dipyridamole ou aspirine seule ?  Academic Article
• Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm  Academic Article
• Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure  Academic Article
• Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: Results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis)  Academic Article
• Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non–ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: Results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial  Academic Article
• Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study  Academic Article
• Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)  Academic Article
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Academic Article
• Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention  Academic Article
• Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: An international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs placebo and clonidine vs placebo in patients undergoing noncardiac surgery  Academic Article
• Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)  Academic Article
• Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study  Academic Article
• Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus  Academic Article
• Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.  Academic Article
• Reasons for resistance to aspirin in cardiovascular disease.  Academic Article
• Recent advances in understanding, diagnosing and treating venous thrombosis  Academic Article
• Recommendations for the Appropriate Use of Anti-Inflammatory Drugs in the Era of the Coxibs: Defining the Role of Gastroprotective Agents  Academic Article
• Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation  Academic Article
• Recurrent spontaneous early pregnancy loss and low dose aspirin.  Academic Article
• Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD  Academic Article
• Reinforcement of Bias in the Medical Literature: Nonsteroidal Anti-inflammatory Drugs and the Stomach—a Case in Poin  Academic Article
• Relation Between Bleeding Time and Platelet Connective Tissue Reaction After Aspirin  Academic Article
• Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin  Academic Article
• Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure  Academic Article
• Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin  Academic Article
• Reply  Academic Article
• Reply  Academic Article
• Reply  Academic Article
• Response by Bagai et al to Letter Regarding Article, “Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention”  Academic Article
• Reversal of the antiplatelet effect of ticagrelor by simulated platelet transfusion  Academic Article
• Reversal of the anti‐platelet effects of aspirin and clopidogrel  Academic Article
• Review of aspirin and clopidogrel resistance in peripheral arterial disease  Academic Article
• Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial  Academic Article
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials  Academic Article
• Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation  Academic Article
• Risk of Thrombosis With Lenalidomide and Its Prevention With Aspirin  Academic Article
• Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES  Academic Article
• Risk of recurrent venous thromboembolism according to baseline risk factor profiles  Academic Article
• Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk  Academic Article
• Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials  Academic Article
• Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis  Academic Article
• Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial  Academic Article
• Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial  Academic Article
• Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction  Academic Article
• Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease  Academic Article
• Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease  Academic Article
• Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization  Academic Article
• Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios  Academic Article
• Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization  Academic Article
• Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial  Academic Article
• Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline  Academic Article
• Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source  Academic Article
• Rivaroxaban in Peripheral Artery Disease after Revascularization  Academic Article
• Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism  Academic Article
• Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial  Academic Article
• Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition  Academic Article
• Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy  Academic Article
• Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial  Academic Article
• Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial  Academic Article
• Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial  Academic Article
• Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease  Academic Article
• Rivaroxaban with or without aspirin for prevention of cardiovascular disease  Academic Article
• Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial  Academic Article
• Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial  Academic Article
• Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion  Academic Article
• Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease  Academic Article
• Role of antithrombotic therapy in atrial fibrillation.  Academic Article
• Role of aspirin for prevention and treatment of perioperative cardiovascular events  Academic Article
• Role of lipoxygenase metabolism in platelet function: Effect of aspirin and salicylate  Academic Article
• Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents  Academic Article
• Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.  Academic Article
• Safer anticoagulant therapy after heart valve replacement  Academic Article
• Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin  Academic Article
• Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS)  Academic Article
• Sekundärprävention nach ischämischem zerebralem Insult  Academic Article
• Selection Bias, Orthopaedic Style  Academic Article
• Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction  Academic Article
• Sensitivity of rabbit platelet and aortic cyclooxygenase to inhibition by aspirin  Academic Article
• Sex differences in the antithrombotic effects of aspirin  Academic Article
• Sex related differences in platelet function: the effect of aspirin  Academic Article
• Sex-related differences in the efficacy of acetylsalicylic acid (ASA): The absorption of ASA and its effect on collagen-induced thromboxane B2 generation  Academic Article
• Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD  Academic Article
• Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention  Academic Article
• Shortening of the bleeding time in thrombocytopenic rabbits after exposure of jugular vein to high aspirin concentration  Academic Article
• Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?  Academic Article
• Should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing  Academic Article
• Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?  Academic Article
• Should we give aspirins and statins to the elderly?  Academic Article
• Should we give aspirins and statins to the elderly?  Academic Article
• Signature Celebration of Gastroenterology , Colorectal Cancer  Academic Article
• Single or Dual Antiplatelet Treatment after TAVI  Academic Article
• Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin  Academic Article
• State of the Art-A Journey through the World of Antithrombotic Therapy  Academic Article
• Steady-state plasma levels of salicylate in patients with rheumatoid arthritis: effects of dosing interval and tablet strength.  Academic Article
• Stroke Outcomes in the COMPASS Trial  Academic Article
• Stroke Prevention in Atrial Fibrillation II Study  Academic Article
• Stroke Prevention in Nonvalvular Atrial Fibrillation  Academic Article
• Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease  Academic Article
• Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey  Academic Article
• Stroke prevention in atrial fibrillation: Closing the gap  Academic Article
• Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial  Academic Article
• Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves.  Academic Article
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease  Academic Article
• THE FREQUENCY OF VENOUS THROMBOSIS IN CEMENTED AND NON-CEMENTED HIP ARTHROPLASTY  Academic Article
• The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal  Academic Article
• The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase  Academic Article
• The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy  Academic Article
• The COMPASS Trial  Academic Article
• The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study.  Academic Article
• The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease  Academic Article
• The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis  Academic Article
• The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients  Academic Article
• The Effect of Thrombin on Platelet Accumulation on the Vessel Wall - Influence of Heparin and Aspirin  Academic Article
• The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population  Academic Article
• The Fat-Mass and Obesity-Associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women  Academic Article
• The HOPE (Heart Outcomes Prevention Evaluation) Study and its Consequences  Academic Article
• The Influence of Red Blood Cells on the Effects of Aspirin or Sulphinpyrazone on Platelet Adherence to Damaged Rabbit Aorta  Academic Article
• The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis  Academic Article
• The Molecular Structure of Human Red Blood Cell Membranes from Highly Oriented, Solid Supported Multi-Lamellar Membranes  Academic Article
• The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial  Academic Article
• The Perioperative Management of Antithrombotic Therapy  Academic Article
• The Primary and Secondary Prevention of Coronary Artery Disease  Academic Article
• The Secondary Prevention of Small Subcortical Strokes (SPS3) Study  Academic Article
• The Use of Platelet Function Assays May Help to Determine Appropriate Antiplatelet Treatment Options in a Patient With Recurrent Stroke on Baby Aspirin  Academic Article
• The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics  Academic Article
• The aspirin controversy in primary prevention  Academic Article
• The beginning of the end of warfarin?  Academic Article
• The cost implications of a polypill for primary prevention in the TIPS-3 trial  Academic Article
• The diagnosis and prevention of post operative venous thrombosis.  Academic Article
• The effect of acetylsalicylic acid and indomethacin on rabbit platelet adherence to collagen and the subendothelium in the presence of a low or high hematocrit  Academic Article
• The effect of antiplatelet therapy on survival and cardiac allograft vasculopathy following heart transplantation: A systematic review and meta‐analysis  Academic Article
• The effect of aspirin inhibition of PGI2 production on platelet adherence to normal and damaged rabbit aortae  Academic Article
• The effect of aspirin on the size of the hemostatic plug  Academic Article
• The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies  Academic Article
• The kinetics of elimination of salicylic acid and the formation of gentisic acid  Academic Article
• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study  Academic Article
• The optimal antithrombotic dose of aspirin  Academic Article
• The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation  Academic Article
• The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect  Academic Article
• The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study  Academic Article
• The reemergence of aspirin for the prevention of venous thromboembolism.  Academic Article
• The role of platelets and platelet inhibition in acute myocardial infarction  Academic Article
• The safety of antithrombotic therapy during pregnancy  Academic Article
• The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects  Academic Article
• There seems to be a low risk of experiencing postoperative bleeding in patients undergoing dental extractions or minor oral surgery who continue using antiplatelet therapy  Academic Article
• Thrombin-induced inositol phosphate production by platelets from rats with diet-induced or genetically determined hypercholesterolemia.  Academic Article
• Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials  Academic Article
• Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.  Academic Article
• Thrombogenic Effect of High-Dose Aspirin in Rabbits  Academic Article
• Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction  Conference Paper
• Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin  Academic Article
• Thrombosis and embolism in pediatric cardiomyopathy  Academic Article
• Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study  Academic Article
• Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study  Academic Article
• Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin  Academic Article
• Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial  Academic Article
• To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections  Academic Article
• Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: Which form of aspirin is the fastest to inhibit platelet aggregation in emergency department patients with non-ST segment elevation myocardial infarction?  Academic Article
• Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial  Academic Article
• Treatment of Acute Coronary Syndromes  Academic Article
• Treatment of Aspirin Exacerbated Respiratory Disease with a Low Salicylate Diet: A Pilot Crossover Study  Academic Article
• Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting  Academic Article
• Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018  Academic Article
• Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism  Academic Article
• Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction  Academic Article
• Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis  Academic Article
• Unstable angina.  Academic Article
• Unstable angina.  Academic Article
• Updated Meta-Analysis of Aspirin in Primary Prevention of Cardiovascular Disease  Academic Article
• Upper gastrointestinal haemorrhage following cardiac surgery  Academic Article
• Use of Combination Evidence-Based Medical Therapy Prior to Acute Myocardial Infarction (from the National Registry of Myocardial Infarction-4)  Academic Article
• Use of antithrombotic agents during pregnancy.  Academic Article
• Use of antithrombotic agents during pregnancy.  Academic Article
• Use of antithrombotic agents during pregnancy.  Academic Article
• Using aspirin to prevent cognitive decline  Academic Article
• Uso de aspirina como profilaxis secundaria en pacientes sin stents coronarios sometidos a cirugía no-cardiaca y cirugía no-endarterectomía carotídea  Academic Article
• Validity of Composite Outcomes in Meta-Analyses of Stroke Prevention Trials: The Case of Aspirin  Academic Article
• Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives  Academic Article
• Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study  Academic Article
• Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms  Academic Article
• Vascular access and antiplatelet therapies: does one influence the other?  Academic Article
• Vascular viewpoint  Academic Article
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014  Academic Article
• Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Academic Article
• Vessel injury, platelet adherence, and platelet survival.  Academic Article
• Vocal cord paralysis secondary to spontaneous internal carotid dissection: case report and systematic review of the literature  Academic Article
• Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial  Academic Article
• Warfarin and Aspirin after Heart-Valve Replacement  Academic Article
• Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm  Academic Article
• Warfarin in Heart Failure  Academic Article
• When guidelines collide  Academic Article
• Will prasugrel supersede clopidogrel for acute coronary syndromes?  Academic Article
• XIX congress of the European Society of Cardiology August 24-28, 1997, Stockholm, Sweden.  Conference Paper
• Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both  Academic Article
• [Antithrombotic treatment of atrial fibrillation].  Academic Article
• [Congestive cardiomyopathy and left intraventricular thrombus as a manifestation of Churg-Strauss syndrome].  Academic Article
• [Prevention of deep vein thrombosis and pulmonary thromboembolism].  Academic Article
• [Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].  Academic Article
• “Part of the Ritual”: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome  Academic Article